Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217789 · ClinicalTrials.gov registry record
Pathogen Specific Immunity in Patients With Sarcoidosis
A clinical trial, sponsored by University of Medicine and Dentistry of New Jersey.
- Completed
- Registry status
- 5
- Enrollment target
NCT00217789: Completed study, sponsored by University of Medicine and Dentistry of New Jersey.
NCT00217789 is a clinical trial that has completed, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217789 has completed, sponsored by University of Medicine and Dentistry of New Jersey.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the lung cells of healthy volunteers and patients with stage II and III pulmonary sarcoidosis for pathogen specific memory immunity and gene expression patterns.
Primary Outcome
Toxicity, DEP-Induced Cytokines, Effect of DEP on Stimulant-Induced Cytokine Production, in vitro Effects of DEP on M.tb-induced Cytokine Production, time kinetics of In vitro effects of DEP on M.tb-induced cytokine production, effect of DEP Exposure on M.tb H37Ra-induced Lymphocyte Proliferation, whole blood killing experiments
Interventions
- PROCEDURE Bronchoalveolar Lavage and Venipuncture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2004-07 |
| Est. Completion | 2008-06 |
What the finished NCT00217789 record still lists
NCT00217789 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Bronchoalveolar Lavage and Venipuncture is the first listed.
NCT00217789 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00217789 about?
NCT00217789 is a clinical study titled "Pathogen Specific Immunity in Patients With Sarcoidosis". The purpose of this study is to assess the lung cells of healthy volunteers and patients with stage II and III pulmonary sarcoidosis for pathogen specific memory immunity and gene expression patterns.
What is the current status of trial NCT00217789?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2004-07. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00217789?
The interventions under investigation include: Bronchoalveolar Lavage and Venipuncture (PROCEDURE).
Who is sponsoring clinical trial NCT00217789?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia